Search - tctmd.com

Displaying 21 - 40 of 59

Sort: Relevancy | Date

News Conference News SCAI 2021

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Michael O'Riordan

April 28, 2021

Presentation SCAI 2020

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Presenter: Benjamin E. Peterson

May 21, 2020

News Conference News SCAI 2020

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

Caitlin E. Cox

May 20, 2020

News Conference News SCAI 2020

PCI at Ambulatory Surgical Centers: Quality Cannot Suffer, SCAI Says

Caitlin E. Cox

May 18, 2020

Presentation SCAI 2020

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

Presenter: Sripal Bangalore

May 16, 2020

News Conference News SCAI 2020

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

Caitlin E. Cox

May 15, 2020

News Conference News SCAI 2019

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

Yael L. Maxwell

June 04, 2019

News Conference News SCAI 2019

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Yael L. Maxwell

June 03, 2019

News Conference News SCAI 2019

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Yael L. Maxwell

May 31, 2019

News Conference News SCAI 2019

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Yael L. Maxwell

May 30, 2019

News Conference News SCAI 2019

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

Yael L. Maxwell

May 24, 2019

News Conference News SCAI 2019

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Yael L. Maxwell

May 23, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

News Conference News SCAI 2018

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Shelley Wood

May 04, 2018

News Conference News SCAI 2018

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

L.A. McKeown

May 01, 2018

Presentation SCAI 2018

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention: A Subgroup analysis of the Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

Presenter: Santiago Garcia

April 28, 2018

Presentation SCAI 2018

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

Presenter: Andrew McNeice

April 28, 2018

Presentation SCAI 2018

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

Presenter: David E. Kandzari

April 28, 2018

Presentation SCAI 2018

The Hybrid Approach to Percutaneous Coronary Intervention for Chronic Total Occlusion: Update from the PROGRESS CTO International Registry

Presenter: Peter Tajti

April 27, 2018

News Conference News SCAI 2018

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

Todd Neale

April 27, 2018

Advertisement

In African-American Patients, Nontraditional Risk Factors Track With Early CAD

Reduction of Revascularization in Patients with Hypertriglyceridemia with Icosapent Ethyl: Insights from REDUCE-IT REVASC

Intermediate Left Main Disease Linked to Worse Outcomes: ISCHEMIA

PCI at Ambulatory Surgical Centers: Quality Cannot Suffer, SCAI Says

Outcomes with Intermediate Left Main Disease on Coronary CT Angiography ISCHEMIA Intermediate LM Substudy

Icosapent Ethyl Lowers Revasc Rates Across the Board: REDUCE-IT Data

FFR Changes Treatment Plan in More Than One-Third of All-Comer Patients

LDL Apheresis Potentially a ‘Head Start’ to Conventional Lipid-Lowering Methods Post-PCI in ACS: PREMIER

Early Bird Bleed Monitoring System Shows Promise in Endovascular Procedures

Cancer and CV Disease Care: What’s Known? What Lies Ahead for Cardio-Oncology?

Antithrombotic Use, Risk Perception, Varies Widely for PCI Patients With A-fib

National Cardiogenic Shock Initiative Shows Potential to Increase Survival

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Interventional Appetite Erodes for Dissolving Polymers and Scaffolds

Coronary Plaques in Psoriasis Patients Change After Treatment With Biologics

Strategies to Reduce Acute Kidney Injury and Improve Clinical Outcomes After Percutaneous Coronary Intervention: A Subgroup analysis of the Prevention of Serious Adverse Events Following Angiography (PRESERVE) Trial

The Prognostic Impact of Revascularization Strategy in Acute Myocardial Infarction and Cardiogenic Shock

PERSPECTIVE Trial: Percutaneous Revascularization at Piedmont for Chronic Total Occlusions Survey

The Hybrid Approach to Percutaneous Coronary Intervention for Chronic Total Occlusion: Update from the PROGRESS CTO International Registry

Doctors, Risk Tools Often at Odds When Assessing Risks in Patients With A-fib Undergoing PCI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content